81 related articles for article (PubMed ID: 12740829)
1. Interaction of hepatitis B virus with cells.
Paran N; Cooper A; Shaul Y
Rev Med Virol; 2003; 13(3):137-43. PubMed ID: 12740829
[TBL] [Abstract][Full Text] [Related]
2. Role of glycosaminoglycans for binding and infection of hepatitis B virus.
Leistner CM; Gruen-Bernhard S; Glebe D
Cell Microbiol; 2008 Jan; 10(1):122-33. PubMed ID: 18086046
[TBL] [Abstract][Full Text] [Related]
3. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein.
Gripon P; Cannie I; Urban S
J Virol; 2005 Feb; 79(3):1613-22. PubMed ID: 15650187
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus infection is dependent on cholesterol in the viral envelope.
Bremer CM; Bung C; Kott N; Hardt M; Glebe D
Cell Microbiol; 2009 Feb; 11(2):249-60. PubMed ID: 19016777
[TBL] [Abstract][Full Text] [Related]
5. Entry of hepatitis B virus: mechanism and new therapeutic target.
Xie Y; Zhai J; Deng Q; Tiollais P; Wang Y; Zhao M
Pathol Biol (Paris); 2010 Aug; 58(4):301-7. PubMed ID: 20570056
[TBL] [Abstract][Full Text] [Related]
6. A chemical lipid modification of recombinant preS antigen to study the mechanism of HBV attachment to the host cell.
Chen B; Lian M; Xu S; Luo M; Zheng X
J Biotechnol; 2008 Oct; 137(1-4):8-13. PubMed ID: 18675858
[TBL] [Abstract][Full Text] [Related]
7. HBV infection of cell culture: evidence for multivalent and cooperative attachment.
Paran N; Geiger B; Shaul Y
EMBO J; 2001 Aug; 20(16):4443-53. PubMed ID: 11500372
[TBL] [Abstract][Full Text] [Related]
8. Attachment sites and neutralising epitopes of hepatitis B virus.
Glebe D
Minerva Gastroenterol Dietol; 2006 Mar; 52(1):3-21. PubMed ID: 16554703
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of bisecting N-acetylglucosaminyltransferase-III gene in a human fetal hepatocyte cell line by hepatitis B virus.
Shim JK; Lee YC; Chung TH; Kim CH
J Gastroenterol Hepatol; 2004 Dec; 19(12):1374-87. PubMed ID: 15610311
[TBL] [Abstract][Full Text] [Related]
10. Asialoglycoprotein receptor interacts with the preS1 domain of hepatitis B virus in vivo and in vitro.
Zhang X; Lin SM; Chen TY; Liu M; Ye F; Chen YR; Shi L; He YL; Wu LX; Zheng SQ; Zhao YR; Zhang SL
Arch Virol; 2011 Apr; 156(4):637-45. PubMed ID: 21207081
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis.
Minami M; Daimon Y; Mori K; Takashima H; Nakajima T; Itoh Y; Okanoue T
Oncogene; 2005 Jun; 24(27):4340-8. PubMed ID: 15806150
[TBL] [Abstract][Full Text] [Related]
12. The HBSP gene is expressed during HBV replication, and its coded BH3-containing spliced viral protein induces apoptosis in HepG2 cells.
Lu YW; Tan TL; Chan V; Chen WN
Biochem Biophys Res Commun; 2006 Dec; 351(1):64-70. PubMed ID: 17049490
[TBL] [Abstract][Full Text] [Related]
13. The immune response induced by hepatitis B virus principal antigens.
Huang CF; Lin SS; Ho YC; Chen FL; Yang CC
Cell Mol Immunol; 2006 Apr; 3(2):97-106. PubMed ID: 16696896
[TBL] [Abstract][Full Text] [Related]
14. Protein profile in hepatitis B virus replicating rat primary hepatocytes and HepG2 cells by iTRAQ-coupled 2-D LC-MS/MS analysis: Insights on liver angiogenesis.
Zhang J; Niu D; Sui J; Ching CB; Chen WN
Proteomics; 2009 May; 9(10):2836-45. PubMed ID: 19405029
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
[TBL] [Abstract][Full Text] [Related]
16. Liver-derived cell lines QSG-7701 and HepG2 support different HBV replication patterns.
Pan XB; Wei L; Chen HS; Liu F; Gao Y
Arch Virol; 2007; 152(6):1159-73. PubMed ID: 17308979
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes.
Baumert TF; Yang C; Schürmann P; Köck J; Ziegler C; Grüllich C; Nassal M; Liang TJ; Blum HE; von Weizsäcker F
Hepatology; 2005 Feb; 41(2):247-56. PubMed ID: 15660384
[TBL] [Abstract][Full Text] [Related]
18. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
[TBL] [Abstract][Full Text] [Related]
19. Modulation of hepatitis B virus replication by expression of polymerase-surface fusion protein through splicing: implications for viral persistence.
Park GS; Kim HY; Shin HS; Park S; Shin HJ; Kim K
Virus Res; 2008 Sep; 136(1-2):166-74. PubMed ID: 18562032
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
